Relationships & familyIdea 1 · 2 min read

Start 0.4 mg of folic acid daily when planning pregnancy and continue through the first three months

Grade A evidenceValue: High
In plain language

Daily folic acid around conception reduces neural tube defects, such as anencephaly and spina bifida, by roughly 70% in the pooled research. Among people with a previous affected pregnancy, recurrence risk was about one-third of that without supplementation. Discuss your dose with a clinician if you have a previous affected pregnancy or other risk factors.

MoneyNo cost
TimeQuick and easy
EffortSome effort

What it takes

A bottle costs tens of RMB in China. China's free folic acid supplementation program provides it to eligible rural women. Taking it daily requires remembering the dose.

What you may gain

A Cochrane review pooled five trials and 6,708 births and rated the evidence high quality. Daily folate supplementation around conception reduced neural tube defects, RR 0.31, 95% CI 0.17–0.58, or about a 70% relative reduction. Recurrence after a previously affected pregnancy had RR 0.34, 95% CI 0.18–0.64, approximately one-third of the comparison risk. Subgroup analyses found no clear difference between 0.4 mg and higher doses or between folic acid alone and combinations with other vitamins; these subgroup findings are not a substitute for individualized high-risk dosing advice.

Context & considerations

Starting before conception is crucial: the neural tube closes within about 28 days after conception, much of which may pass before a positive pregnancy test. The source recommends starting three months before trying to conceive. The same review found no clear effect on cleft lip or palate, congenital heart disease, or miscarriage; folic acid is not a remedy for every pregnancy risk.

Research & references

De-Regil LM, Peña-Rosas JP, Fernández-Gaxiola AC, Rayco-Solon P (2015). Effects and safety of periconceptional oral folate supplementation for preventing birth defects. Cochrane Database of Systematic Reviews, (12), CD007950. https://doi.org/10.1002/14651858.CD007950.pub3